272 related articles for article (PubMed ID: 32005973)
1. AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics.
Qi M; Dai D; Liu J; Li Z; Liang P; Wang Y; Cheng L; Zhan Y; An Z; Song Y; Yang Y; Yan X; Xiao H; Shao H
Oncogene; 2020 Mar; 39(13):2707-2723. PubMed ID: 32005973
[TBL] [Abstract][Full Text] [Related]
2. AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway.
Zhang M; Jin C; Yang Y; Wang K; Zhou Y; Zhou Y; Wang R; Li T; Hu R
J Cell Physiol; 2019 Nov; 234(11):20161-20173. PubMed ID: 30953357
[TBL] [Abstract][Full Text] [Related]
3. SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway.
Fu L; Dong Q; He J; Wang X; Xing J; Wang E; Qiu X; Li Q
Oncogene; 2017 May; 36(19):2724-2736. PubMed ID: 27941873
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics.
Xie D; Wu X; Lan L; Shangguan F; Lin X; Chen F; Xu S; Zhang Y; Chen Z; Huang K; Wang R; Wang L; Song X; Liu Y; Lu B
Oncotarget; 2016 Mar; 7(10):11609-24. PubMed ID: 26820294
[TBL] [Abstract][Full Text] [Related]
5. CHAF1B promotes proliferation and reduces apoptosis in 95‑D lung cancer cells and predicts a poor prognosis in non‑small cell lung cancer.
Duan Y; Liu T; Li S; Huang M; Li X; Zhao H; Li J
Oncol Rep; 2019 Apr; 41(4):2518-2528. PubMed ID: 30720130
[TBL] [Abstract][Full Text] [Related]
6. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways.
Huang Q; Zhan L; Cao H; Li J; Lyu Y; Guo X; Zhang J; Ji L; Ren T; An J; Liu B; Nie Y; Xing J
Autophagy; 2016 Jun; 12(6):999-1014. PubMed ID: 27124102
[TBL] [Abstract][Full Text] [Related]
7. Positive feedback loop between mitochondrial fission and Notch signaling promotes survivin-mediated survival of TNBC cells.
Chen L; Zhang J; Lyu Z; Chen Y; Ji X; Cao H; Jin M; Zhu J; Yang J; Ling R; Xing J; Ren T; Lyu Y
Cell Death Dis; 2018 Oct; 9(11):1050. PubMed ID: 30323195
[TBL] [Abstract][Full Text] [Related]
8. ROCK1 knockdown inhibits non-small-cell lung cancer progression by activating the LATS2-JNK signaling pathway.
Xin T; Lv W; Liu D; Jing Y; Hu F
Aging (Albany NY); 2020 Jun; 12(12):12160-12174. PubMed ID: 32554853
[TBL] [Abstract][Full Text] [Related]
9. EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non‑small cell lung cancer cells.
Gao L; Yang T; Zhang S; Liang Y; Shi P; Ren H; Hou P; Chen M
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907840
[TBL] [Abstract][Full Text] [Related]
10. EPB41 suppresses the Wnt/β-catenin signaling in non-small cell lung cancer by sponging ALDOC.
Yuan J; Xing H; Li Y; Song Y; Zhang N; Xie M; Liu J; Xu Y; Shen Y; Wang B; Zhang L; Yang M
Cancer Lett; 2021 Feb; 499():255-264. PubMed ID: 33242559
[TBL] [Abstract][Full Text] [Related]
11. An epigenetic increase in mitochondrial fission by MiD49 and MiD51 regulates the cell cycle in cancer: Diagnostic and therapeutic implications.
Dasgupta A; Chen KH; Wu D; Hoskin V; Mewburn J; Lima PDA; Parlow LRG; Hindmarch CCT; Martin A; Sykes EA; Tayade C; Lightbody ED; Madarnas Y; SenGupta SK; Elliott BE; Nicol CJB; Archer SL
FASEB J; 2020 Apr; 34(4):5106-5127. PubMed ID: 32068312
[TBL] [Abstract][Full Text] [Related]
12. Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment.
Yu Q; Zhang M; Ying Q; Xie X; Yue S; Tong B; Wei Q; Bai Z; Ma L
Cell Death Dis; 2019 Mar; 10(3):218. PubMed ID: 30833546
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
14. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
15. Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.
Zhang J; Sun B; Ruan X; Hou X; Zhi J; Meng X; Zheng X; Gao M
Cancer Biol Med; 2021 Feb; 18(1):105-119. PubMed ID: 33628588
[TBL] [Abstract][Full Text] [Related]
16. Depletion of end-binding protein 1 (EB1) promotes apoptosis of human non-small-cell lung cancer cells via reactive oxygen species and Bax-mediated mitochondrial dysfunction.
Kim MJ; Yun HS; Hong EH; Lee SJ; Baek JH; Lee CW; Yim JH; Kim JS; Park JK; Um HD; Hwang SG
Cancer Lett; 2013 Oct; 339(1):15-24. PubMed ID: 23900080
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC.
Che TF; Lin CW; Wu YY; Chen YJ; Han CL; Chang YL; Wu CT; Hsiao TH; Hong TM; Yang PC
Oncotarget; 2015 Nov; 6(35):37349-66. PubMed ID: 26497368
[TBL] [Abstract][Full Text] [Related]
18. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
[TBL] [Abstract][Full Text] [Related]
20. QiDongNing induces lung cancer cell apoptosis via triggering P53/DRP1-mediated mitochondrial fission.
Ding R; Wang Y; Xu L; Sang S; Wu G; Yang W; Zhang Y; Wang C; Qi A; Xie H; Liu Y; Dai A; Jiao L
J Cell Mol Med; 2024 May; 28(9):e18353. PubMed ID: 38682742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
